Notable Labs Stock Performance
| NTBL Stock | 0.40 0.01 2.56% |
The company secures a Beta (Market Risk) of 3.01, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Notable Labs will likely underperform. At this point, Notable Labs has a negative expected return of -0.29%. Please make sure to verify Notable Labs' kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Notable Labs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Notable Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain quite persistent which may send shares a bit higher in November 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Last Split Factor 1:35 | Last Split Date 2023-10-17 |
1 | Notable Labs receives FDA clearance to proceed with Volasertib phase 2 study | 07/24/2024 |
2 | Divis Laboratories Share Price Today Live Updates Divis Laboratories Sees 4.82 percent Price Surge, Average ... - The Economic Times | 07/26/2024 |
3 | Acquisition by Patsi Tuomo of 65247 shares of Notable Labs subject to Rule 16b-3 | 08/02/2024 |
4 | Notable Labs Q2 Earnings Snapshot | 08/15/2024 |
5 | Notable Labs Announces CEO Transition | 08/26/2024 |
6 | Divis Laboratories Share Price Live Updates Divis Laboratories Sees Modest Daily Gain and Positive We... - The Economic Times | 09/05/2024 |
7 | Insider Trading | 09/16/2024 |
8 | This PepsiCo Analyst Is No Longer Bullish Here Are Top 5 Downgrades For Friday | 09/20/2024 |
9 | Notable Labs, Ltd. Sees Large Increase in Short Interest | 10/01/2024 |
| Begin Period Cash Flow | 1.6 M |
Notable |
Notable Labs Relative Risk vs. Return Landscape
If you would invest 55.00 in Notable Labs on July 8, 2024 and sell it today you would lose (15.00) from holding Notable Labs or give up 27.27% of portfolio value over 90 days. Notable Labs is currently does not generate positive expected returns and assumes 6.5505% risk (volatility on return distribution) over the 90 days horizon. In different words, 58% of stocks are less volatile than Notable, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Notable Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Notable Labs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Notable Labs, and traders can use it to determine the average amount a Notable Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0448
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NTBL |
Estimated Market Risk
| 6.55 actual daily | 58 58% of assets are less volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Notable Labs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Notable Labs by adding Notable Labs to a well-diversified portfolio.
Notable Labs Fundamentals Growth
Notable Stock prices reflect investors' perceptions of the future prospects and financial health of Notable Labs, and Notable Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Notable Stock performance.
| Return On Equity | -4.64 | ||||
| Return On Asset | -1.06 | ||||
| Current Valuation | 1.57 M | ||||
| Shares Outstanding | 9.66 M | ||||
| Price To Book | 0.54 X | ||||
| Price To Sales | 12.34 X | ||||
| Revenue | 310 K | ||||
| Gross Profit | 8 K | ||||
| EBITDA | (19.35 M) | ||||
| Net Income | (11.26 M) | ||||
| Total Debt | 2.05 M | ||||
| Book Value Per Share | 0.74 X | ||||
| Cash Flow From Operations | (13.72 M) | ||||
| Earnings Per Share | (1.09) X | ||||
| Market Capitalization | 3.86 M | ||||
| Total Asset | 19.54 M | ||||
| Retained Earnings | (82.31 M) | ||||
| Working Capital | 12.73 M | ||||
About Notable Labs Performance
By examining Notable Labs' fundamental ratios, stakeholders can obtain critical insights into Notable Labs' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Notable Labs is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 5.3 K | 5.6 K | |
| Return On Tangible Assets | (0.58) | (0.61) | |
| Return On Capital Employed | (0.87) | (0.92) | |
| Return On Assets | (0.58) | (0.61) | |
| Return On Equity | (0.75) | (0.71) |
Things to note about Notable Labs performance evaluation
Checking the ongoing alerts about Notable Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Notable Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Notable Labs generated a negative expected return over the last 90 days | |
| Notable Labs has high historical volatility and very poor performance | |
| Notable Labs has some characteristics of a very speculative penny stock | |
| Notable Labs has a very high chance of going through financial distress in the upcoming years | |
| Notable Labs was previously known as Vascular Biogenics and was traded on NASDAQ Exchange under the symbol VBLT. | |
| The company reported the previous year's revenue of 310 K. Net Loss for the year was (11.26 M) with profit before overhead, payroll, taxes, and interest of 8 K. | |
| Notable Labs generates negative cash flow from operations | |
| Notable Labs has a poor financial position based on the latest SEC disclosures | |
| About 33.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Notable Labs, Ltd. Sees Large Increase in Short Interest |
- Analyzing Notable Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Notable Labs' stock is overvalued or undervalued compared to its peers.
- Examining Notable Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Notable Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Notable Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Notable Labs' stock. These opinions can provide insight into Notable Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Information and Resources on Investing in Notable Stock
When determining whether Notable Labs is a strong investment it is important to analyze Notable Labs' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Notable Labs' future performance. For an informed investment choice regarding Notable Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Notable Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Notable Stock please use our How to buy in Notable Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Notable Labs. If investors know Notable will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Notable Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share 0.042 | Return On Assets (1.06) | Return On Equity (4.64) |
The market value of Notable Labs is measured differently than its book value, which is the value of Notable that is recorded on the company's balance sheet. Investors also form their own opinion of Notable Labs' value that differs from its market value or its book value, called intrinsic value, which is Notable Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Notable Labs' market value can be influenced by many factors that don't directly affect Notable Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Notable Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Notable Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Notable Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.